104 related articles for article (PubMed ID: 3763479)
41. [Pathohistological characteristics of myelodysplastic syndromes: diagnostic and prognostic significance].
Marisavljević D; Cemerikić V; Rolović Z; Bosković D; Colović M
Srp Arh Celok Lek; 2005; 133(3-4):162-9. PubMed ID: 16206706
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromes.
Dörmer P; Hershko C; Wilmanns W
Br J Haematol; 1987 Oct; 67(2):147-52. PubMed ID: 3676103
[TBL] [Abstract][Full Text] [Related]
43. Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.
Vido JR; Adam RL; Lorand-Metze IG; Metze K
Diagn Pathol; 2011 Sep; 6():93. PubMed ID: 21958512
[TBL] [Abstract][Full Text] [Related]
44. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
45. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
[TBL] [Abstract][Full Text] [Related]
46. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
Thiele J; Hoffmann I; Bertsch HP; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604
[TBL] [Abstract][Full Text] [Related]
47. [Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia].
Gu LL; Kang HY; Pan YL; Liu GX; Ge SJ; Li MY; Wang CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):138-43. PubMed ID: 26913410
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic significance of morbidly hematopoietic characteristics in 69 patients with myelodysplastic syndrome].
Wu YN; Luo ZB; Wang C; Li J; Luo HY; He DY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):150-4. PubMed ID: 25687064
[TBL] [Abstract][Full Text] [Related]
49. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
Liu SQ; Liu XF; Song SJ
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
[TBL] [Abstract][Full Text] [Related]
50. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells.
Thiele J; Titius BR; Quitmann H; Fischer R; Salzberger B; Dienemann D; Stein H
Pathol Res Pract; 1992 Aug; 188(6):722-8. PubMed ID: 1437834
[TBL] [Abstract][Full Text] [Related]
51. The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes.
Lambertenghi Deliliers G; Annaloro C; Soligo D; Oriani A
Leuk Lymphoma; 1998 Jan; 28(3-4):231-9. PubMed ID: 9517495
[TBL] [Abstract][Full Text] [Related]
52. [Myelodysplastic syndromes].
Dusek J; Bednár B; Dorazilová V; Fakan F; Kerekes Z
Cesk Patol; 1990 Aug; 26(3):129-34. PubMed ID: 2208324
[TBL] [Abstract][Full Text] [Related]
53. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.
Raza A; Mundle S; Iftikhar A; Gregory S; Marcus B; Khan Z; Alvi S; Shetty V; Dameron S; Wright V
Am J Hematol; 1995 Mar; 48(3):143-54. PubMed ID: 7864021
[TBL] [Abstract][Full Text] [Related]
54. A prospective analysis of prognostic factors in the myelodysplastic syndromes.
Knottenbelt E; Jacobs P; Wilson EL
S Afr Med J; 1990 Jan; 77(2):69-74. PubMed ID: 2296740
[TBL] [Abstract][Full Text] [Related]
55. The challenging task of enumerating blasts in the bone marrow.
Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
[TBL] [Abstract][Full Text] [Related]
56. Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients.
Coiffier B; Adeleine P; Gentilhomme O; Felman P; Treille-Ritouet D; Bryon PA
Cancer; 1987 Dec; 60(12):3029-32. PubMed ID: 3677025
[TBL] [Abstract][Full Text] [Related]
57. Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog.
Weiss DJ; Aird B
Vet Clin Pathol; 2001; 30(2):67-75. PubMed ID: 12024319
[TBL] [Abstract][Full Text] [Related]
58. Histological features of bone marrow in paediatric patients during the asymptomatic phase of early-stage Black African sickle cell anaemia.
Mauriello A; Giacobbi E; Saggini A; Isgrò A; Facchetti S; Anemona L
Pathology; 2017 Apr; 49(3):297-303. PubMed ID: 28238414
[TBL] [Abstract][Full Text] [Related]
59. Ultrastructural observations on bone marrow cells of 26 patients with myelodysplastic syndromes.
Cohen AM; Alexandrova S; Bessler H; Mittelman M; Cycowitz Z; Djaldetti M
Leuk Lymphoma; 1997 Sep; 27(1-2):165-72. PubMed ID: 9373208
[TBL] [Abstract][Full Text] [Related]
60. Is apoptosis a massive process in myelodysplastic syndromes?
Lepelley P; Campergue L; Grardel N; Preudhomme C; Cosson A; Fenaux P
Br J Haematol; 1996 Nov; 95(2):368-71. PubMed ID: 8904894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
